Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00065988 · ClinicalTrials.gov registry record · Phase 3

The Children's Amalgam Trial

A Phase 3 study of Dental Caries, sponsored by Carelon Research.

Completed
Registry status
Phase 3
Development phase
534
Enrollment target
1
Study location

NCT00065988 is a Phase 3 study of Dental Caries that has completed, run by Carelon Research. The registered enrollment target is 534 participants, below the 704-participant average among 30 other Dental Caries trials with a reported enrollment target (24% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00065988, a Phase 3 study of Dental Caries, has completed, sponsored by Carelon Research.

COMPLETED
Registry status
Phase 3
Development phase
534 participants
Enrollment target
1
Study location

Study Summary

The Children's Amalgam Trial is one of only two randomized trials of its kind, and the only such trial in the United States, to address the potential impact of mercury exposure from amalgam restorations on neuropsychological and renal function in children.

Conditions Studied

Interventions

  • DEVICE Dispersed phase amalgam restoration /composite restoration

Study Locations (1)

Massachusetts

  • New England Research Institute - Watertown

Trial Details

FieldValue
Enrollment Target 534 participants
Start Date 1997-09
Est. Completion 2005-03
Phase Phase 3

Sponsor

Carelon Research

50 total trials

What the Registry Record Tells You About NCT00065988

The ClinicalTrials.gov registry entry for NCT00065988 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 534 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 704-participant average among 30 other Dental Caries trials with a reported enrollment target (24% lower). The listed sponsor is Carelon Research, which has 50 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Dental Caries appearing as the primary indexed condition, and to 1 intervention - of which Dispersed phase amalgam restoration /composite restoration is the first listed.

NCT00065988 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT00065988 about?

NCT00065988 is a clinical study titled "The Children's Amalgam Trial". The Children's Amalgam Trial is one of only two randomized trials of its kind, and the only such trial in the United States, to address the potential impact of mercury exposure from amalgam restorations on neuropsychological and renal function in children.

What is the current status of trial NCT00065988?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 534 participants. The study started on 1997-09. Estimated completion is 2005-03.

What conditions does trial NCT00065988 study?

This clinical trial studies the following conditions: Dental Caries.

What interventions are being tested in trial NCT00065988?

The interventions under investigation include: Dispersed phase amalgam restoration /composite restoration (DEVICE).

Who is sponsoring clinical trial NCT00065988?

This trial is sponsored by Carelon Research, which has 50 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00065988 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Dental Caries

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.